Should we use SSRIs to treat adolescents with depression?

MOspace/Manakin Repository

Please use this identifier to cite or link to this item: http://hdl.handle.net/10355/3630

File: ShouldUseSSRIsTreatAdolescents.pdf 87.66Kb

Show File

MIME type: application/pdf

Title:	Should we use SSRIs to treat adolescents with depression?
Author:	Kane, Erin Purtell; Fagan, Heather Bittner; Wolf, Diane G.
Keywords:	depressive disorder suicidal behavior morbidity cognitive behavioral therapy
Date:	2007-09
Publisher:	Family Physicians Inquiries Network
Citation:	Journal of Family Practice, 56(9) 2007: 759-760.
Abstract:	Yes. B ased on current evidence, fluoxetine is the most effective selective serotonin reuptake inhibitor (SSRI) for treatment of major depressive disorder in adolescents. It is the only agent approved by the US Food and Drug Administration (FDA) for use in children (strength of recommendation [SOR]: A, based on meta-analysis of RCTs). All SSRI medications increase the risk of suicidal behavior in adolescents, but do not increase the risk of completing suicide (SOR: A, based on meta-analysis of RCTs).
URI:	http://hdl.handle.net/10355/3630